Resisting resistance: New chemical strategies for battling superbugs

Chemistry and Biology

Volumn 7, Issue 6, 2000, Pages

  Wright, Gerard D ^a  

^a MCMASTER UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0034123845     PISSN: 10745521     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1074-5521(00)00126-5     Document Type: Review

References (38)

1. Davies J. Inactivation of antibiotics and the dissemination of resistance genes. Science. 264:1994;375-382.
2. Davies J., Webb V. Antibiotic resistance in bacteria. Krause R.M. Emerging infections. 1998;239-273 Academic Press, San Diego.
3. Diekema D.J., Jones R.N. Oxazolidinones. Drugs. 59:2000;7-16.
4. Canepari P., Boaretti M. Lipoteichoic acid as a target for antimicrobial action. Microb. Drug Resist. 2:1996;85-89.
5. Renau T.E., Hecker S.J., Lee V.J. Antimicrobial potentiation approaches: Targets and inhibitors. Ann. Rep. Med. Chem. 33:1998;121-130.
6. Bush K., Mobashery S. How β-lactamases have driven pharmaceutical drug discovery. From mechanistic knowledge to clinical circumvention. Adv. Exp. Med. Biol. 456:1998;71-98.
7. Sutherland R. β-lactamase inhibitors and reversal of antibiotic resistance. Trends Pharmacol. Sci. 12:1991;227-232.
8. Wright A.J. The penicillins. Mayo Clin. Proc. 74:1999;290-307.
9. Chaibi E.B., Sirot D., Paul G., Labia R. Inhibitor-resistant TEM β-lactamases: phenotypic, genetic and biochemical characteristics. J. Antimicrob. Chemother. 43:1999;447-458.
10. Richter H.G., Winkler F.K.et al. Design, synthesis, and evaluation of 2 β-alkenyl penam sulfone acids as inhibitors of β-lactamases. J. Med. Chem. 39:1996;3712-3722.
11. Heinze-Krauss I., Winkler F.et al. Structure-based design of β-lactamase inhibitors. 1. Synthesis and evaluation of bridged monobactams. J. Med. Chem. 41:1998;3961-3971.
12. Wright G.D. Aminoglycoside-modifying enzymes. Curr. Opin. Microbiol. 2:1999;499-503.
13. Allen N.E. Jr., Alborn W.E.A. Jr., Hobbs J.N.H., Kirst H.A. 7-Hydroxytropolone: An inhibitor of aminoglycoside-2″-O-adenyltransferase. Antimicrob. Agents Chemother. 22:1982;824-831.
14. Roestamadji J., Grapsas I., Mobashery S. Mechanism-based inactivation of bacterial aminoglycoside 3′-phosphotransferases. J. Am. Chem. Soc. 117:1995;80-84.
15. Haddad J., Vakulenko S., Mobashery S. An antibiotic cloaked by its own resistance enzyme. J. Am. Chem. Soc. 121:1999;11922-11923.
16. Daigle D.M., McKay G.A., Thompson P.R., Wright G.D. Aminoglycoside antibiotic phosphotransferases are also serine protein kinases. Chem. Biol. 6:1999;11-18.
17. Hon W.C., Berghuis A.M.et al. Structure of an enzyme required for aminoglycoside antibiotic resistance reveals homology to eukaryotic protein kinases. Cell. 89:1997;887-895.
18. Daigle D.M., McKay G.A., Wright G.D. Inhibition of aminoglycoside antibiotic resistance enzymes by protein kinase inhibitors. J. Biol. Chem. 272:1997;24755-24758.
19. Arthur M., Brisson-Noël A., Courvalin P. Origin and evolution of genes specifying resistance to macrolide, lincosamide and streptogramin antibiotics: data and hypotheses. J. Antimicrob. Chemother. 20:1987;783-802.
20. Clancy J., McGuirk P.R.et al. Assays to detect and characterize synthetic agents that inhibit the ErmC methyltransferase. J. Antibiot. 48:1995;1273-1279.
21. Shuker S.B., Hajduk P.J., Meadows R.P., Fesik S.W. Discovering high-affinity ligands for proteins: SAR by NMR. Science. 274:1996;1531-1534.
22. Hajduk P.J., Gerfin T., Boehlen J.M., Haberli M., Marek D., Fesik S.W. High-throughput nuclear magnetic resonance-based screening. J. Med. Chem. 42:1999;2315-2317.
23. Hajduk P.J., Fesik S.W.et al. Novel inhibitors of Erm methyltransferases from NMR and parallel synthesis. J. Med. Chem. 42:1999;3852385-3852389.
24. Levy S.B. Active efflux mechanisms for antimicrobial resistance. Antimicrob. Agents Chemother. 36:1992;695-703.
25. Sum P.E., Sum F.W., Projan S.J. Recent developments in tetracycline antibiotics. Curr. Pharm. Des. 4:1998;119-132.
26. Nelson M.L., Park B.H., Andrews J.S., Georgian V.A., Thomas R.C., Levy S.B. Inhibition of the tetracycline efflux antiport protein by 13-thio- substituted 5-hydroxy-6-deoxytetracyclines. J. Med. Chem. 36:1993;370-377.
27. Nelson M.L., Levy S.B. Reversal of tetracycline resistance mediated by different bacterial tetracycline resistance determinants by an inhibitor of the Tet(B) antiport protein. Antimicrob. Agents Chemother. 43:1999;1719-1724.
28. Hancock R.E. Resistance mechanisms in Pseudomonas aeruginosa and other nonfermentative gram-negative bacteria. Clin. Infect. Dis. 27(Suppl 1):1998;S93-S99.
29. Nikaido H. Antibiotic resistance caused by gram-negative multidrug efflux pumps. Clin. Infect. Dis. 27(Suppl 1):1998;S32-S41.
30. Poole K. Bacterial multidrug resistance-emphasis on efflux mechanisms and Pseudomonas aeruginosa. J. Antimicrob. Chemother. 34:1994;453-456.
31. Poole K., Nishino T.et al. Overexpression of the mexC-mexD-oprJ efflux operon in nfxB-type multidrug-resistant strains of Pseudomonas aeruginosa. Mol. Microbiol. 21:1996;713-724.
32. Kohler T., Michea-Hamzehpour M., Henze U., Gotoh N., Curty L.K., Pechere J.C. Characterization of MexE-MexF-OprN, a positively regulated multidrug efflux system of Pseudomonas aeruginosa. Mol. Microbiol. 23:1997;345-354.
33. Mine T., Morita Y., Kataoka A., Mizushima T., Tsuchiya T. Expression in Escherichia coli of a new multidrug efflux pump, MexXY, from Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 43:1999;415-417.
34. Neyfakh A.A., Borsch C.M., Kaatz G.W. Fluoroquinolone resistance protein NorA of Staphylococcus aureus is a multidrug efflux transporter. Antimicrob. Agents Chemother. 37:1993;128-129.
35. Hsieh P.C., Siegel S.A., Rogers B., Davis D., Lewis K. Bacteria lacking a multidrug pump: a sensitive tool for drug discovery. Proc. Natl Acad. Sci. USA. 95:1998;6602-6606.
36. Markham P.N., Neyfakh A.A. Inhibition of the multidrug transporter NorA prevents emergence of norfloxacin resistance in Staphylococcus aureus. Antimicrob. Agents Chemother. 40:1996;2673-2674.
37. Markham P.N., Westhaus E., Klyachko K., Johnson M.E., Neyfakh A.A. Multiple novel inhibitors of the NorA multidrug transporter of Staphylococcus aureus. Antimicrob. Agents Chemother. 43:1999;2404-2408.
38. Stermitz F.R., Lorenz P., Tawara J.N., Zenewicz L.A., Lewis K. Synergy in a medicinal plant: antimicrobial action of berberine potentiated by 5′-methoxyhydnocarpin, a multidrug pump inhibitor. Proc. Natl Acad. Sci. USA. 97:2000;1433-1437.